Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Krystal Biotech (KRYS)
NASDAQ:KRYS
Krystal Biotech (KRYS) Stock Price & Analysis
263 Followers
KRYS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$47.67 - $85.65
Previous Close$80.21
Volume120.91K
Average Volume (3M)175.74K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$394.42M
Total Debt (Recent Filing)$9.12M
Price to Earnings (P/E)-15.4
Beta0.17
Next EarningsMar 14, 2023
EPS Estimate-$1.26
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$106.50
EPS (TTM)-5.21
Shares Outstanding25,747,647
R-Squared0.08
Standard Deviation0.16
10 Day Avg. Volume149,583
30 Day Avg. Volume175,744
Price to Book (P/B)3.96
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-17.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside33.21% Upside
Rating ConsensusStrong Buy
Alpha0.04
Number of Analyst Covering5
Krystal Biotech News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KRYS FAQ
What was Krystal Biotech’s price range in the past 12 months?
Krystal Biotech lowest stock price was $47.67 and its highest was $85.65 in the past 12 months.
What is Krystal Biotech’s market cap?
Currently, no data Available
When is Krystal Biotech’s upcoming earnings report date?
Krystal Biotech’s upcoming earnings report date is Mar 14, 2023 which is in 35 days.
How were Krystal Biotech’s earnings last quarter?
Krystal Biotech released its earnings results on Nov 07, 2022. The company reported -$1.17 earnings per share for the quarter, beating the consensus estimate of -$1.188 by $0.018.
Is Krystal Biotech overvalued?
According to Wall Street analysts Krystal Biotech’s price is currently Undervalued.
Does Krystal Biotech pay dividends?
Krystal Biotech does not currently pay dividends.
What is Krystal Biotech’s EPS estimate?
Krystal Biotech’s EPS estimate is -$1.26.
How many shares outstanding does Krystal Biotech have?
Krystal Biotech has 25,747,646 shares outstanding.
What happened to Krystal Biotech’s price movement after its last earnings report?
Krystal Biotech reported an EPS of -$1.17 in its last earnings report, beating expectations of -$1.188. Following the earnings report the stock price went up 6.611%.
Which hedge fund is a major shareholder of Krystal Biotech?
Among the largest hedge funds holding Krystal Biotech’s share is Deerfield Management Company, LP. It holds Krystal Biotech’s shares valued at 12M.
---
Krystal Biotech Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$106.50
$106.50
Blogger Sentiment
Bullish
KRYS Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 175.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.78%
12-Months-Change
Fundamentals
Return on Equity
-27.34%
Trailing 12-Months
Asset Growth
27.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Krystal Biotech
Krystal Biotech, Inc. is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases for which company believe there are no known effective treatments. The company was founded by Suma M. Krishnan in December 2017 and is headquartered in Pittsburgh, PA.
---
Relay Therapeutics
―
Akero Therapeutics
―
ProKidney
―
ImmunityBio
―
Revolution Medicines
―
---